National consultations on the cultivation of cannabis for domestic use and export are taking place in Saint Lucia, as the Caribbean country debates plans to diversify its agricultural industry. Saint Lucia is among an ever-shrinking group of countries in the Caribbean that have yet to enact cannabis reforms, either decriminalization or legalization for medical or adult use.
Canadian and U.S. cannabis companies are facing a spike in already high costs of insurance to protect top executives from personal liability, following a slew of lawsuits by disgruntled investors alleging fraud and misinformation, with more such action expected.
Some of the biggest cannabis companies, including Medmen Enterprises, Canopy Growth, CannTrust Holdings, Aphria Inc and Columbia Care, have faced shareholder litigation, accusing leaders of false claims, failing to act in the interest of all shareholders and attempts to defraud investors.
Illinois marijuana dispensaries sold more than $47.6 million worth of products in June, according to the Illinois Department of Financial and Professional Regulation.
During that time, 994,545 items were sold, averaging almost $48 per purchase, not including taxes. Tax figures will be released later this month by the Illinois Department of Revenue.
Those sales figures will likely lead to another record in tax revenue for the state, as well.
2020 has not lived up to expectations for the global cannabis industry and much of the blame can be attributed to COVID-19. Going forward, we believe that the industry is poised to record growth as lockdown orders start to get lifted in provinces across Canada and in the European Union (EU).
The cannabis industry is booming. Sales for state-legal cannabis businesses are projected to reach close to $30 billion by 2025. Yet most of these businesses are still reliant on cash to run their business. And that can cause a lot of trouble.
But digital payments — and FinTech companies like AeroPay — have the opportunity to disrupt this long underserved industry. Here’s how:
Hemp breeding is big business, and as such, companies who invest in breeding programs are also investing in protections.
With the hemp boom upon us, plant scientists have turned their attention to creating new and innovative hemp cultivars. The focus is on varieties for specific climates, special disease or environmental resistance, or unique cannabinoid profiles.
Lawmakers in the House of Representatives have advanced a highways infrastructure bill that includes language making products from state-legal cannabis markets available for federal research purposes.
Will Congress act soon to bring a measure of common sense to this country’s cannabis policy? What about the states?
The glacial pace at which the federal government has implemented cannabis policy–particularly in light of the rapid evolution of cannabis laws at the state level–is at the same time predictable and frustrating to those seeking a measure of certainty. And it begs the question: Will Congress act soon to bring a measure of common sense to this country’s cannabis policy? What about the states?
One Upstate county welcomes the hemp industry as a way to reinvigorate its economy.
Nestled near the confluence of the Susquehanna and Chenango rivers in Upstate New York, the city of Binghamton and the surrounding county, Broome, was always a hotbed of agriculture and manufacturing. From the rivers to railroads to highways, the area has been at the hub of transportation networks and grew steadily through the 20th century.
Until recently, the term “telehealth” was known in the medical community, but not the cannabis community.
Since the COVID-19 outbreak sent the country into lockdown, medical marijuana users in many states can now check in with a health care provider by video for authorization, rather than an in-person meeting.
According to MPP.org, 31 states currently allow telemedicine for cannabis patients – 11 of which have temporarily altered their laws as a result of the current coronavirus pandemic.
